AIM ImmunoTech Inc.
AIMI
$0.0765
$0.008512.50%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 45.00K | 35.00K | 50.00K | 40.00K | 65.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.00K | 35.00K | 50.00K | 40.00K | 65.00K |
| Cost of Revenue | 7.00K | 8.00K | 8.00K | 8.00K | 12.00K |
| Gross Profit | 38.00K | 27.00K | 42.00K | 32.00K | 53.00K |
| SG&A Expenses | 4.32M | 3.08M | 2.59M | 3.92M | 10.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.90M | 4.52M | 3.74M | 5.77M | 14.07M |
| Operating Income | -5.86M | -4.49M | -3.69M | -5.73M | -14.00M |
| Income Before Tax | -5.97M | -3.70M | -1.84M | -5.82M | -12.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.97M | -3.70M | -1.84M | -5.82M | -12.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.97M | -3.70M | -1.84M | -5.82M | -12.58M |
| EBIT | -5.86M | -4.49M | -3.69M | -5.73M | -14.00M |
| EBITDA | -5.79M | -4.43M | -3.63M | -5.68M | -13.95M |
| EPS Basic | -0.09 | -0.06 | -0.03 | -0.12 | -0.26 |
| Normalized Basic EPS | -0.06 | -0.04 | -0.02 | -0.07 | -0.17 |
| EPS Diluted | -0.09 | -0.06 | -0.03 | -0.12 | -0.26 |
| Normalized Diluted EPS | -0.06 | -0.04 | -0.02 | -0.07 | -0.17 |
| Average Basic Shares Outstanding | 64.01M | 57.68M | 52.84M | 49.46M | 48.89M |
| Average Diluted Shares Outstanding | 64.01M | 57.68M | 52.84M | 49.46M | 48.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |